drugset / Trial / NCT01054911

Evaluation of Patients With Bulky GIST Using Sunitinib

NCT01054911

NaSingle-groupOpen-labelTreatment

Summary

The primary purpose of this study is to determine if oral (mouth) delivery prior to tumor removal in patients with gastrointestinal stromal tumor (GIST) results in tumor shrinkage allowing for successful surgery. Therapy will be administered orally and the response of the tumor will be assessed using CTs or MRIs.

Timeline

Start
2009-10
Primary completion
2014-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Sunitinib Small molecule 37.5 mg Oral

Indications